Invesaro

Stocks Comparison

Balchem vs Ingevity: revenue, profit, margins and growth compared

Balchem brought in $1B of revenue in fiscal 2025, Ingevity $1.2B in fiscal 2025. Revenue changed by +8.8% at Balchem and -2.7% at Ingevity on the year before, so Balchem grew faster. Balchem kept 14.9% of its revenue as net profit, Ingevity -14.3%.

Side by side, latest fiscal year

BCPCNGVT
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$1B$1.2B
Revenue growth+8.8%-2.7%
Net income$154.8M-$167.1M
Net margin14.9%-14.3%
Free cash flown/a$273.5M
Free cash flow marginn/a23.4%
Earnings per share (diluted)$4.75-$4.61
Cash$74.6M$78.1M
Debtn/a$47.1M
Price to earnings35.4n/a
Market value$5.4B$2.5B
Dividend yield0.57%n/a
Rank by revenue in sector#269 of 451 · Industrials#259 of 451 · Industrials

Over the years

Revenue
BCPC FY2018: $643.7MBCPC FY2019: $643.7MBCPC FY2020: $703.6MBCPC FY2021: $799MBCPC FY2022: $942.4MBCPC FY2023: $922.4MBCPC FY2024: $953.7MBCPC FY2025: $1BNGVT FY2018: $1.1BNGVT FY2019: $1.3BNGVT FY2020: $1.2BNGVT FY2021: $1.4BNGVT FY2022: $1.7BNGVT FY2023: $1.2BNGVT FY2024: $1.2BNGVT FY2025: $1.2BFY18FY19FY20FY21FY22FY23FY24FY25
BCPC $1BNGVT $1.2B
Net income
BCPC FY2018: $78.6MBCPC FY2019: $79.7MBCPC FY2020: $84.6MBCPC FY2021: $96.1MBCPC FY2022: $105.4MBCPC FY2023: $108.5MBCPC FY2024: $128.5MBCPC FY2025: $154.8MNGVT FY2018: $169.1MNGVT FY2019: $183.7MNGVT FY2020: $181.4MNGVT FY2021: $118.1MNGVT FY2022: $211.6MNGVT FY2023: -$5.4MNGVT FY2024: -$430.3MNGVT FY2025: -$167.1MFY18FY19FY20FY21FY22FY23FY24FY25
BCPC $154.8MNGVT -$167.1M
Net margin
BCPC FY2018: 12.2%BCPC FY2019: 12.4%BCPC FY2020: 12.0%BCPC FY2021: 12.0%BCPC FY2022: 11.2%BCPC FY2023: 11.8%BCPC FY2024: 13.5%BCPC FY2025: 14.9%NGVT FY2018: 14.9%NGVT FY2019: 14.2%NGVT FY2020: 14.9%NGVT FY2021: 8.5%NGVT FY2022: 12.7%NGVT FY2023: -0.4%NGVT FY2024: -35.9%NGVT FY2025: -14.3%FY18FY19FY20FY21FY22FY23FY24FY25
BCPC 14.9%NGVT -14.3%
Revenue growth
BCPC FY2019: +0.0%BCPC FY2020: +9.3%BCPC FY2021: +13.6%BCPC FY2022: +17.9%BCPC FY2023: -2.1%BCPC FY2024: +3.4%BCPC FY2025: +8.8%NGVT FY2019: +14.1%NGVT FY2020: -5.9%NGVT FY2021: +14.4%NGVT FY2022: +19.9%NGVT FY2023: -27.1%NGVT FY2024: -1.3%NGVT FY2025: -2.7%FY19FY20FY21FY22FY23FY24FY25
BCPC +8.8%NGVT -2.7%
Free cash flow
BCPC FY2018: $99.5MBCPC FY2019: $98.7MBCPC FY2020: $118.4MBCPC FY2021: $124.4MBCPC FY2022: $89.5MNGVT FY2018: $158.1MNGVT FY2019: $160.9MNGVT FY2020: $270.3MNGVT FY2021: $189.5MNGVT FY2022: $170.9MNGVT FY2023: $95.3MNGVT FY2024: $51MNGVT FY2025: $273.5MFY18FY19FY20FY21FY22FY23FY24FY25
BCPC $89.5MNGVT $273.5M

Fiscal years as each company reports them; the two may end in different months.

Questions about Balchem and Ingevity

Which is bigger by revenue, Balchem or Ingevity?

Ingevity is bigger by revenue: $1.2B in fiscal 2025, against $1B for Balchem in fiscal 2025.

Which keeps more of its revenue as profit, Balchem or Ingevity?

Balchem had a net margin of 14.9% in fiscal 2025; Ingevity had -14.3% in fiscal 2025.

Which grew revenue faster, Balchem or Ingevity?

In their latest fiscal years revenue changed by +8.8% at Balchem and -2.7% at Ingevity.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies